Rasburicase
DrugBank ID: DB00049
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| obsolete hyperuricemia (disease) | 0.9999 | KG+DL |
| hypouricemia, renal | 0.9999 | DL |
| hypoxanthine guanine phosphoribosyltransferase partial deficiency | 0.9997 | DL |
| hepatic porphyria | 0.9997 | DL |
| early-onset familial noncirrhotic portal hypertension | 0.9997 | DL |
| hepatoportal sclerosis | 0.9997 | DL |
| hepatopulmonary syndrome | 0.9997 | DL |
| idiopathic copper-associated cirrhosis | 0.9997 | DL |
| primitive portal vein thrombosis | 0.9997 | DL |
| renal tubular acidosis | 0.9985 | DL |
| disorder of phenylalanine metabolism | 0.9983 | DL |
| disorder of tyrosine metabolism | 0.9969 | DL |
| teratogenic Pierre Robin syndrome | 0.9968 | DL |
| glycogen storage disease due to hepatic glycogen synthase deficiency | 0.9958 | DL |
| Lesch-Nyhan syndrome | 0.9958 | DL |
| tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | 0.9947 | DL |
| G6PD deficiency | 0.9900 | DL |
| inborn disorder of gamma-aminobutyric acid metabolism | 0.9773 | DL |
| inborn disorder of ornithine metabolism | 0.9768 | DL |
| inborn disorder of amino acid and other organic acid metabolism | 0.9766 | DL |
| inborn disorder of histidine metabolism | 0.9766 | DL |
| inborn disorder of serine family metabolism | 0.9765 | DL |
| cerebral creatine deficiency syndrome | 0.9762 | DL |
| genetic otorhinolaryngological malformation | 0.9750 | DL |
| inborn disorder of aspartate family metabolism | 0.9747 | DL |
| neonatal epileptic encephalopathy due to glutaminase deficiency | 0.9745 | DL |
| inborn disorder of tryptophan metabolism | 0.9742 | DL |
| 2-methylacetoacetyl CoA thiolase deficiency | 0.9733 | DL |
| idiopathic bilateral vestibulopathy | 0.9725 | DL |
| semicircular canal dehiscence syndrome | 0.9725 | DL |
| 3-hydroxyisobutyryl-CoA hydrolase deficiency | 0.9711 | DL |
| inborn disorder of phenylalanin or tyrosine metabolism | 0.9678 | DL |
| familial nasal acilia | 0.9654 | DL |
| tetrahydrobiopterin metabolic process disease | 0.9654 | DL |
| juvenile nasopharyngeal angiofibroma (disease) | 0.9649 | DL |
| silent sinus syndrome | 0.9645 | DL |
| 3-hydroxyisobutyric aciduria | 0.9636 | DL |
| maternal hyperthermia induced birth defects | 0.9592 | DL |
| mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies | 0.9591 | DL |
| cleft lip/palate-intestinal malrotation-cardiopathy syndrome | 0.9584 | DL |
| fetal trimethadione syndrome | 0.9578 | DL |
| craniorhiny | 0.9565 | DL |
| Bencze syndrome | 0.9561 | DL |
| phenobarbital embryopathy | 0.9560 | DL |
| fetal minoxidil syndrome | 0.9556 | DL |
| diabetic embryopathy | 0.9555 | DL |
| tibial aplasia-ectrodactyly syndrome | 0.9555 | DL |
| mandibulofacial dysostosis-macroblepharon-macrostomia syndrome | 0.9538 | DL |
| branchial cleft anomaly | 0.9531 | DL |
| galactokinase deficiency | 0.9503 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.